Pleuropulmonary Complications and Pulmonary Function Changes After Esophageal Variceal Sclerotherapy: An Experience From Upper Egypt

Sherif A.A. Mohamed; Zain El–Abdeen A. Sayed; Mohamed O. Abd El–Malek

Volume : III, Issue : XII, December - 2014

Pleuropulmonary Complications and Pulmonary Function Changes After Esophageal Variceal Sclerotherapy: An Experience From Upper Egypt

Sherif A. A. Mohamed, Zain El Ndash Abdeen A. Sayed, Mohamed O. Abd El Ndash Malek

Abstract :

Background:To report our experience with pleuropulmonary complications and pulmonary function changes in patients underwent esophageal variceal sclerotherapy (EVS), in Upper Egypt. Methods:Patients with bleeding varices who underwent elective EVS were followed up for pleuropulmonary symptoms, and were subjected to ABGs measurements and spirometric evaluation before EVS, which were compared to those 2 days, and 3 weeks after EVS. Results: During a 3-years period, 188 patients were enrolled. Most reported symptoms were chest pain in 39%, dyspnea in 32.4%, and dysphagia in 26% of patients. Mediastinal widening was encountered in 33%, pleural effusion in 24%, and atelectasis in 16.5% of patients. Restrictive ventilatory defect was found early and late after EVS. Hypoxemia occurred early after EVS which improved after 3 weeks, with no changes in PACO2. Conclusion: Our results showed pleuropulmonary complications and restrictive dysfunction similar to those reported in literature. These effects, were generally mild, well-tolerated by the patients, and with no mortality